Gastric Band v Gastric Sleeve

Summary: In 2026 this is barely a comparison. The LAP-BAND was discontinued by Apollo Endosurgery in 2023, fewer than 1% of new bariatric cases are bands, and sleeve gastrectomy delivers roughly 60 to 70% excess weight loss with far lower reoperation rates.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short version: in 2026 this is not a real choice. The gastric band, marketed in the US as LAP-BAND, was discontinued by Apollo Endosurgery in 2023 and now accounts for under 1% of US bariatric cases ^[2][3]. Sleeve gastrectomy is the dominant procedure, with roughly 60 to 70% excess weight loss at two to five years and a reoperation rate a fraction of what the band produced ^[4]. If a clinic is still pushing a band in 2026, ask why. The data has been telling surgeons to stop offering it for a decade.

Here is what each procedure actually is, what the long-term numbers look like, why bands collapsed in popularity, and what the modern bariatric hierarchy now recommends.

How each procedure works

Gastric band (laparoscopic adjustable gastric banding, LAGB). A silicone ring is wrapped around the very top of the stomach, creating a small upper pouch about the size of a golf ball. A tube runs from the band to a port placed under the skin, usually on the abdominal wall. The surgeon injects or removes saline through that port to tighten or loosen the band. Tighter band, smaller opening to the rest of the stomach, faster fullness. No stomach tissue is cut or removed. No rerouting of the intestines. The mechanism is purely mechanical restriction.

Sleeve gastrectomy (vertical sleeve gastrectomy, VSG). The surgeon staples and removes roughly 75 to 80% of the stomach along its outer curve, leaving a narrow banana-shaped tube about the size and shape of a large sleeve of crackers. The fundus, which is the dome of the stomach that produces most of the body's ghrelin, is gone. That is the key part. Sleeve does not just shrink the tank, it kills the hunger hormone factory. Gastric emptying for solids slows. The pyloric valve and intestines are left intact, so there is no malabsorption.

The sleeve is permanent and the band is reversible. That sounds like a point in the band's favor, and twenty years ago surgeons sold it that way. The trouble is the band's reversibility became its dominant clinical outcome. People did not remove their band because their weight loss went so well. They removed it because it failed.

Expected weight loss

Excess weight loss, abbreviated %EWL in the bariatric literature, is the percentage of weight above the patient's ideal body weight that gets lost after surgery. A patient 100 pounds over ideal who loses 60 pounds has 60% EWL.

The numbers from the long-term comparative literature:

• Sleeve gastrectomy: roughly 60 to 70% excess weight loss at 2 years, holding around 50 to 60% at 5 to 7 years ^[4]. Total body weight loss runs about 25 to 30%.
• Gastric band: roughly 40 to 50% excess weight loss at 2 years in the best series, regressing toward 30 to 40% at 5 years and lower beyond that ^[5]. Total body weight loss runs about 15 to 20%.
• Roux-en-Y gastric bypass (RYGB): roughly 65 to 75% excess weight loss at 2 years, 55 to 65% long term.
• Duodenal switch and SADI-S: 75 to 85% excess weight loss, the highest of any approved procedure, with corresponding nutritional risk.

The headline number people miss: band weight loss is also the slowest. Sleeve and bypass patients hit most of their weight loss in the first 12 to 18 months. Band patients are still climbing toward their plateau at 2 to 3 years if they ever get there. For most patients living with metabolic disease, that delay is itself a clinical problem because the comorbidities (diabetes, sleep apnea, hypertension) keep doing damage during the slow weight loss curve.

Risks and complications

Both procedures are laparoscopic and the 30-day mortality for either is well under 1% in high-volume centers. The difference is what happens in years 2, 5, and 10.

Gastric band complications. Slippage, where the band moves and the stomach prolapses through it. Erosion, where the band slowly works its way through the stomach wall. Port problems, including infection, flipping, disconnection from the tubing. Esophageal dilation from chronic obstruction at the band. Reflux. Inability to swallow solids if the band is tightened too far. Almost universal need for adjustment visits in the first year, then ongoing maintenance forever. The most cited long-term number: roughly 30 to 50% of bands are removed within 10 years, the majority for complications or inadequate weight loss ^[5]. Some series put the removal rate above 50%.

Gastric sleeve complications. Staple line leak, the feared early complication, occurs in roughly 1 to 2% of cases. Strictures along the sleeve, treatable endoscopically. Bleeding. A real and well-documented issue: GERD (acid reflux) worsens or develops de novo in a meaningful minority of sleeve patients, with rates around 20 to 30% reporting new or worsened reflux long term. Some sleeve patients ultimately convert to gastric bypass specifically for refractory reflux. Nutritional deficiencies are less common than with bypass but iron, B12, and vitamin D supplementation are standard.

Reversibility, recovery, and what it actually feels like

The band is removable. The sleeve is not. That distinction sounds like an advantage for the band until you ask what removal actually means in clinical practice. People who have their band removed usually regain most or all of the weight they lost. The sleeve removes anatomy you cannot regrow. The band leaves anatomy that does not work without the device.

Recovery. Sleeve recovery is roughly 2 to 4 weeks back to desk work, 6 weeks back to lifting. Band recovery is faster on paper (1 to 2 weeks) because no stomach was cut, but the diet progression from liquids to purees to solids is similar to sleeve. The band requires a structured series of adjustment appointments over the first year to find the right restriction level, which sleeve does not.

Diet long term. Sleeve patients can eat almost any food in small portions long term, with most learning that very dense carbohydrates, large gulps of liquid with meals, and carbonation are uncomfortable. Band patients live with whatever opening the band creates, and many report difficulty with bread, pasta, fibrous meats, and anything that does not chew down to liquid. Vomiting from food impaction at the band is common, and chronic vomiting is the proximate cause of many band removals.

Cost and insurance

In the US, bariatric surgery is increasingly covered by commercial insurance, Medicare, and many Medicaid programs when patients meet criteria. The 2022 ASMBS and IFSO position statement expanded eligibility, recommending surgery for adults with BMI greater than or equal to 35 regardless of comorbidities, and for BMI 30 to 34.9 with metabolic disease ^[1]. That was a meaningful liberalization of the older 1991 NIH criteria.

Cash prices in 2026 for a sleeve in a US center of excellence run roughly $15,000 to $25,000. Bands, where still performed, run $10,000 to $18,000. Insurance coverage requires documentation of a supervised weight loss attempt, psychological evaluation, nutritional counseling, and often a body mass index threshold. The exact requirements vary by carrier.

In the UK, sleeve gastrectomy is available through the NHS for patients meeting NICE criteria, with a multi-year referral and tier-3 weight management pathway before approval. Bands are still occasionally placed on the NHS but the trend matches the US: away from bands.

Why bands fell out of favor

The band's collapse is one of the cleanest examples of evidence reshaping practice in modern surgery. In the late 1990s and 2000s, the LAP-BAND was marketed as the safer, reversible, adjustable alternative to bypass. Allergan, which owned LAP-BAND through 2013, ran extensive direct-to-consumer advertising. The procedure peaked at about 35% of all US bariatric cases around 2008.

Three things happened.

Long-term data caught up. As patients passed the 5 and 10 year marks, the failure rate became impossible to ignore. The original randomized and observational studies that supported approval mostly had 2-year follow-up. By 2015, multi-center series were reporting reoperation rates above 30%, and meta-analyses were showing band weight loss regressing toward baseline in a significant fraction of patients ^[5].

The sleeve emerged. Sleeve gastrectomy went from a first-stage procedure for duodenal switch to a standalone operation in the mid-2000s. By 2013 it had passed bypass as the most common US bariatric procedure. It produced better weight loss than the band with no implant and no adjustment visits.

GLP-1 medications changed the calculus. Semaglutide and tirzepatide approval for weight loss further compressed the niche where bands made sense. Patients who in 2005 might have chosen a band for modest weight loss with reversibility now have non-surgical options that produce comparable or better outcomes.

By the time Apollo Endosurgery announced it was discontinuing LAP-BAND production in 2023, US case volumes had already fallen to a small fraction of the bariatric mix ^[2][3]. Some surgeons still place existing inventory, and revision surgeries on legacy bands continue, but new band placements are increasingly rare.

The 2026 bariatric hierarchy

The current ASMBS-aligned procedure hierarchy, in roughly the order they are recommended for typical adult patients with severe obesity:

1. Sleeve gastrectomy is the default first-line procedure for most adult bariatric patients. Best balance of weight loss, durability, complication rate, and lifestyle impact.
2. Roux-en-Y gastric bypass (RYGB) is the preferred procedure for patients with significant GERD, type 2 diabetes (where bypass has a slight metabolic edge), or BMI above roughly 50 where greater weight loss is needed.
3. Duodenal switch (BPD-DS) is reserved for the highest BMI patients and the most experienced centers. Highest weight loss, highest nutritional risk.
4. SADI-S (single anastomosis duodeno-ileal bypass with sleeve) is a newer simplification of duodenal switch with one anastomosis instead of two. Comparable weight loss to BPD-DS, lower technical complexity.
5. Endoscopic sleeve gastroplasty (ESG) is a non-surgical option that sutures the stomach into a narrow tube. Less weight loss than surgical sleeve (about 15 to 20% total body weight loss), but no incisions and no resection.
6. Intragastric balloon is a 6-month temporary device for modest weight loss, typically 10 to 15% total body weight loss while in place, with high regain after removal.
7. Gastric band is not in the standard recommended sequence for new patients in 2026.

Gastric bypass v gastric sleeve, briefly

Since this question always rides alongside the band comparison: sleeve and Roux-en-Y gastric bypass are the two procedures most current adult bariatric candidates choose between.

• Bypass produces slightly more weight loss (roughly 65 to 75% EWL vs 60 to 70%) and slightly better diabetes remission, particularly in patients with longstanding insulin-treated diabetes.
• Sleeve is technically simpler, has a shorter operative time, no anastomosis to leak, and no malabsorptive component.
• Bypass causes some dumping syndrome (rapid GI symptoms after sugar) which most surgeons consider a feature for weight loss, not a bug. Sleeve typically does not.
• Bypass requires lifelong supplementation including B12, iron, calcium, vitamin D, and a multivitamin. Sleeve requires similar supplementation but malabsorption is less aggressive.
• Bypass is preferred for GERD. Sleeve can worsen reflux.

The choice between sleeve and bypass is real and individualized. The choice between band and either of them is mostly historical.

Common questions

Is the gastric band still being done in 2026?

Rarely. Apollo Endosurgery discontinued LAP-BAND production in 2023, and bands now account for under 1% of US bariatric cases. A small number of surgeons still place existing inventory, but new placements are uncommon and ASMBS does not list the band as a first-line option for new patients.

How much weight do you lose with gastric band v gastric sleeve?

Sleeve patients typically lose 60 to 70% of excess weight at 2 years, holding around 50 to 60% long term. Band patients average 40 to 50% at 2 years and many regress further by year 5. The sleeve also reaches the plateau faster, usually within 12 to 18 months.

Can a gastric band be removed?

Yes. The band is fully reversible and removal is a laparoscopic procedure. Most patients who have a band removed regain most or all of the weight they lost. A subset go on to revision surgery with a sleeve or bypass after band removal.

Can a gastric sleeve be reversed?

No. Once 75 to 80% of the stomach is removed and stapled, the resected tissue cannot be restored. Revision surgery from sleeve to bypass or duodenal switch is possible, but reversal to a normal stomach is not.

Is gastric bypass better than gastric sleeve?

Bypass produces slightly more weight loss and slightly better diabetes remission, particularly for insulin-treated type 2 diabetes. Sleeve is technically simpler with no anastomosis. Bypass is preferred for patients with significant reflux. For most patients, the choice depends on their specific metabolic profile and GERD status.

What are the side effects of gastric banding surgery?

Slippage, erosion of the band into the stomach wall, port problems, esophageal dilation, severe reflux, food intolerance, frequent vomiting from impaction, and the need for ongoing adjustment visits. Roughly 30 to 50% of bands are removed within 10 years, largely for these complications or inadequate weight loss.

What are the side effects of gastric bypass?

Anastomotic leak (1 to 2%), strictures, marginal ulcers, internal hernias, dumping syndrome after sugar, lifelong risk of vitamin and mineral deficiencies (B12, iron, calcium, vitamin D), and a small risk of late hypoglycemia. Long-term complications are uncommon at high-volume centers but lifelong supplementation and follow-up are required.

Sleeve gastrectomy vs gastric balloon, which works better?

Sleeve produces about twice the total body weight loss of a balloon and the result is durable. Balloons are temporary (typically 6 months in place), produce 10 to 15% total body weight loss while in place, and most patients regain a significant fraction after removal. Balloons are a bridge tool, sleeve is a definitive procedure.

What is SADI-S vs gastric sleeve?

SADI-S (single anastomosis duodeno-ileal bypass with sleeve) starts with a sleeve and adds an intestinal bypass loop. Total weight loss is higher than sleeve alone (75 to 85% EWL) but nutritional monitoring is more intensive. SADI-S is typically reserved for higher BMI patients or as a revision after inadequate sleeve weight loss.

Does insurance cover bariatric surgery in the US?

Most commercial insurance, Medicare, and many state Medicaid programs cover sleeve and bypass for patients meeting criteria, which usually include BMI thresholds, documented prior weight loss attempts, psychological evaluation, and nutritional counseling. Band coverage is increasingly limited because most carriers follow ASMBS guidance.

Can you have a band replaced with a sleeve?

Yes. Conversion from band to sleeve is one of the most common bariatric revisions in the 2020s. It is usually done as a single procedure (band removal plus sleeve) or staged in two operations depending on the surgeon and the local tissue condition.

Is gastric banding NHS available?

NHS bariatric services in 2026 prioritize sleeve and bypass based on NICE guidance and patient factors. Bands are still occasionally offered but uncommonly compared to a decade ago, mirroring the global shift away from the device.

The bottom line

Gastric band v gastric sleeve in 2026 reads less like a clinical decision and more like a history lesson. The band was a defensible choice in 2005. By 2015 the long-term data had turned. By 2023 the dominant US manufacturer had pulled the device. The sleeve, with better weight loss, fewer reoperations, no implant to maintain, and an effect on hunger hormones the band cannot match, has become the default operation for most adults needing bariatric surgery. The remaining live questions for a new patient are not band versus sleeve. They are sleeve versus bypass, and increasingly, surgery versus GLP-1 medication versus a combination of both. Bring those questions to a bariatric center of excellence and ask for the citations behind whatever they recommend.